Aplicaciones de smartphone para pacientes con cáncer; ¿qué conocemos sobre ellas?

The randomized phase 3 BEACON (BrEAst Cancer Outcomes with NKTR-102; registered with ClinicalTri- als.gov number NCT01492101) study was designed to compare the overall survival

Women aged less than or equal to 40 years old, with breast cancer, are patients from urban areas, overweight, with one to four children and no family history of breast cancer,

We propose a study to analyse the efficacy and cost utility of a music intervention programme, applied as complementary therapy, for cancer patients in palliative care and for

The aim of the present study was to investigate acromegaly prevalence in patients who are referred to sleep units for suspected sleep apnea syndrome and who also have symptoms of

Our results, achieved using 145 plasma samples from colorectal cancer (CRC) patients, patients carrying premalignant colorectal lesions, and controls, demonstrated that ΔNp73 showed

Molecular testing guideline for the selection of patients with lung cancer for treatment with targeted tyrosine kinase inhibitors: American Society of Clinical Oncol- ogy

Pembrolizu- mab (P) in patients (pts) with metastatic breast cancer (MBC) with high tumor mutational burden (HTMB): results from the targeted agent and profiling utiliza- tion

The two major breast cancer susceptibility genes BRCA1 and BRCA2 are involved in 30% of hereditary breast cancer cases, but the discovery of additional breast cancer